Key facts
- OrganiCore’s last known valuation is $25.0M (Jan 2026).
- Notable investors include Acequia Capital.
- 1 investment vehicle was formed to buy OrganiCore shares in the last 12 months, reporting $75K sold to 7 investors, per SEC Form D filings.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for OrganiCore
- ·The full record, as it builds
Funding rounds
No funding rounds for OrganiCore are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Secondary demand: investment vehicles
from SEC Form D filingsIn the last 12 months, 1 investment vehicle were formed to buy OrganiCore shares, reporting $75K sold to 7 investors. Most recent filing Nov 2025. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.
About OrganiCore
The company is currently operating in stealth mode.
- Sector
- Business Products and Services (B2B)
- HQ
- New York, NY, United States
- Ownership
- Privately Held (backing)
OrganiCore doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in OrganiCore shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on OrganiCore in its N-PORT filings yet. We sweep new filings monthly.